THE McGILL CONSENSUS STATEMENT
On May 24-25, 2002, a Symposium was held at McGill University in Montreal,
Quebec, Canada during which fifteen scientists and expert clinicians discussed
the efficacy of overdentures for the treatment of edentulous patients. Strong
emphasis was given to evidence from randomized controlled trials in which
mandibular 2-implant overdentures were compared to conventional dentures.
A draft consensus statement was circulated to all presenters, as well as to
subjects who participated in some of the clinical trials and other edentulous
individuals who attended the Symposium. The statement was modified during the
meeting in light of their comments.
The McGill Consensus Statement on Overdentures: Mandibular two-implant
overdentures as first choice standard of care for edentulous patients
A panel of experts who work in areas relevant to the consensus question, as well
as patients and clinical trial participants who have experience with dental
prostheses prepared this Consensus Statement.